Publications

Detailed Information

The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans

DC Field Value Language
dc.contributor.authorChoi, Su-Yeon-
dc.contributor.authorKim, Donghee-
dc.contributor.authorKim, Hwa Jung-
dc.contributor.authorKang, Jin Hwa-
dc.contributor.authorPark, Min Jung-
dc.contributor.authorKim, Chung Hyun-
dc.contributor.authorKim, Won-
dc.contributor.authorYoon, Jung-Hwan-
dc.contributor.authorCho, Sang-Heon-
dc.contributor.authorOh, Byung-Hee-
dc.contributor.authorSung, Myung-Whun-
dc.contributor.authorLee, Hyo-Suk-
dc.contributor.authorKim, Yoon Jun-
dc.contributor.authorChoi, Seung Ho-
dc.contributor.authorKim, Young Sun-
dc.contributor.authorChung, Su Jin-
dc.date.accessioned2012-05-24T05:30:25Z-
dc.date.available2012-05-24T05:30:25Z-
dc.date.issued2009-08-
dc.identifier.citationAMERICAN JOURNAL OF GASTROENTEROLOGY; Vol.104 8; 1953-1960ko_KR
dc.identifier.issn0002-9270-
dc.identifier.urihttps://hdl.handle.net/10371/76407-
dc.description.abstractOBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is known to be related to factors that predict the development of coronary heart disease (CHD), such as dyslipidemia, central obesity, and metabolic syndrome (MS). The aim of this study was to determine whether individuals with NAFLD have an elevated risk of CHD, as estimated using the Framingham risk score (FRS). METHODS: A total of 21,130 individuals who underwent a voluntary general health examination were recruited. NAFLD was diagnosed among these individuals on the basis of typical sonographic findings and a level of alcohol consumption of <20 g/day. Of the 21,130 individuals, 3,780 were excluded because they had known causes of liver disease (1,690 were alcoholics, 975 had hepatitis B virus, 242 had hepatitis C virus, 91 had other hepatitis history, and 593 were taking medication known to produce fatty liver) or a history of heart disease (189). RESULTS: NAFLD was diagnosed in 5,769 of the 17,350 individuals (33.3%). The 11,581 normal individuals constituted the control group. The 5,769 individuals with NAFLD were split into two groups on the basis of ultrasonographic findings, that is, into a mild NAFLD group (n=3,278) and a moderate-severe NAFLD group (n=2,491). Individuals with NAFLD had an elevated risk of CHD, as estimated using FRS. Multivariable regression analysis, adjusted for confounding factors, showed a strong association between a higher FRS and NAFLD. CONCLUSIONS: Individuals with ultrasonographically detected NAFLD have an elevated 10-year risk of developing CHD as estimated using FRS. Furthermore, NAFLD was found to be independently related to the risk of developing CHD, regardless of classical risk factors and other components of MS.ko_KR
dc.language.isoenko_KR
dc.publisherNATURE PUBLISHING GROUPko_KR
dc.titleThe Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreansko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor최수연-
dc.contributor.AlternativeAuthor김동희-
dc.contributor.AlternativeAuthor김화정-
dc.contributor.AlternativeAuthor강진화-
dc.contributor.AlternativeAuthor정수진-
dc.contributor.AlternativeAuthor박민정-
dc.contributor.AlternativeAuthor김영순-
dc.contributor.AlternativeAuthor김정현-
dc.contributor.AlternativeAuthor최승호-
dc.contributor.AlternativeAuthor김원-
dc.contributor.AlternativeAuthor김윤준-
dc.contributor.AlternativeAuthor윤정환-
dc.contributor.AlternativeAuthor이효석-
dc.contributor.AlternativeAuthor조상헌-
dc.contributor.AlternativeAuthor성명훈-
dc.contributor.AlternativeAuthor오병희-
dc.identifier.doi10.1038/ajg.2009.238-
dc.citation.journaltitleAMERICAN JOURNAL OF GASTROENTEROLOGY-
dc.description.citedreferenceCHOI SY, 2008, KOREAN J HEPATOL, V14, P77-
dc.description.citedreferenceKronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONHA.106.674143-
dc.description.citedreferenceTargher G, 2007, ATHEROSCLEROSIS, V191, P235, DOI 10.1016/j.atherosclerosis.2006.08.021-
dc.description.citedreferenceSchindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006-
dc.description.citedreferenceZelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x-
dc.description.citedreferenceBudoff MJ, 2006, ATHEROSCLEROSIS, V187, P343, DOI 10.1016/j.atherosclerosis.2005.09.013-
dc.description.citedreferenceIoannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171-
dc.description.citedreferenceMcCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17-
dc.description.citedreferenceMARCHESINI G, 2006, MINERVA CARDIOANGIOL, V54, P229-
dc.description.citedreferenceTargher G, 2005, DIABETES, V54, P3541-
dc.description.citedreferenceMusso G, 2005, HEPATOLOGY, V42, P1175, DOI 10.1002/hep.20896-
dc.description.citedreferenceAdams LA, 2005, DIABETIC MED, V22, P1129-
dc.description.citedreferenceBrea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18-
dc.description.citedreferenceEckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7-
dc.description.citedreferencePagano C, 2005, EUR J ENDOCRINOL, V152, P113-
dc.description.citedreferenceLIN YC, 2005, WORLD J GASTROENTERO, V11, P4838-
dc.description.citedreferenceBrowning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466-
dc.description.citedreferenceTargher G, 2004, DIABETES CARE, V27, P2498-
dc.description.citedreferenceTargher G, 2004, DIABETES CARE, V27, P2085, DOI 10.2337/diacare.27.8.2085-
dc.description.citedreferenceGrundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E-
dc.description.citedreferenceHui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280-
dc.description.citedreferenceLiu J, 2004, JAMA-J AM MED ASSOC, V291, P2591-
dc.description.citedreferenceBEDOGNI G, 2004, ANN HEPATOL, V3, P63-
dc.description.citedreferenceKern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779-
dc.description.citedreferenceMofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229-
dc.description.citedreferenceNeuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193-
dc.description.citedreferenceHense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2-
dc.description.citedreferenceJoy D, 2003, EUR J GASTROEN HEPAT, V15, P539, DOI 10.1097/01.meg.0000059112.41030.2e-
dc.description.citedreferenceIpekci SH, 2003, J CLIN GASTROENTEROL, V36, P371-
dc.description.citedreferenceRuhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004-
dc.description.citedreferenceClark JM, 2003, GASTROENTEROLOGY, V124, P248, DOI 10.1053/gast.2003.50032-
dc.description.citedreferenceSaadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354-
dc.description.citedreferenceSakkinen P, 2002, J CLIN EPIDEMIOL, V55, P445-
dc.description.citedreferencePagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690-
dc.description.citedreferenceUnger RH, 2002, ANNU REV MED, V53, P319-
dc.description.citedreferenceOLEARY DH, 2002, AM J CARDIOL, V90, P18-
dc.description.citedreferenceSANYAL AJ, 2002, GASTROENTEROLOGY, V123, P1705-
dc.description.citedreferenceYano E, 2001, J CLIN EPIDEMIOL, V54, P945-
dc.description.citedreferenceCleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486-
dc.description.citedreferenceKern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745-
dc.description.citedreferenceSanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256-
dc.description.citedreferenceRidker PM, 2000, NEW ENGL J MED, V342, P836-
dc.description.citedreference*WHO IASO IOTF, 2000, AS PAC PERSP RED OB-
dc.description.citedreferenceWilson PWF, 1998, CIRCULATION, V97, P1837-
dc.description.citedreferenceJOSEPH AEA, 1991, CLIN RADIOL, V43, P26-
dc.description.tc7-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share